A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy

BACKGROUND: Because of rapid disease progression and lack of optimal treatment strategies beyond the second‐line, the prognosis of patients with extensive‐stage (ES) small cell lung cancer (SCLC) still remains depressing. Alternative treatment strategies are required to improve their prognosis. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yutao, Hu, Xingsheng, Jiang, Jun, Yang, Lin, Zhou, Shengyu, Liu, Peng, Li, Junling, Wang, Yan, Hao, Xuezhi, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216448/
https://www.ncbi.nlm.nih.gov/pubmed/32250517
http://dx.doi.org/10.1634/theoncologist.2019-0391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216448/
https://www.ncbi.nlm.nih.gov/pubmed/32250517
http://dx.doi.org/10.1634/theoncologist.2019-0391

Ejemplares similares